Keith Murphy

Insider Reports History

Location
San Diego, CA
Signature
/s/ Norman Staskey, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keith Murphy:

Company Role Class Num Shares Value Price $ Report Date Ownership
VivoSim Labs, INC. EXECUTIVE CHAIRMAN, Director Common Stock 26,053 $49,649 $1.91 27 Jan 2026 Direct
Kintara Therapeutics, Inc. Director Options (Right to Buy) 100,000 22 Sep 2021 Direct
Matinas BioPharma Holdings, Inc. Director Stock Option (right to Buy) 11,600 30 Apr 2025 Direct

Insider Reports Filed by Keith Murphy

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VIVS VivoSim Labs, INC. 27 Jan 2026 1 $0 4 EXECUTIVE CHAIRMAN, Director 29 Jan 2026, 19:59
MTNB Matinas BioPharma Holdings, Inc. 30 Apr 2025 1 $0 4 Director 02 May 2025, 17:19
MTNB Matinas BioPharma Holdings, Inc. 11 Mar 2025 0 $0 3 Director 17 Mar 2025, 17:30
VIVS ORGANOVO HOLDINGS, INC. 05 Aug 2024 3 $0 4 EXECUTIVE CHAIRMAN, Director 07 Aug 2024, 16:01
VIVS ORGANOVO HOLDINGS, INC. 17 Nov 2023 1 $0 4 Executive Chairman, Director 17 Nov 2023, 18:37
VIVS ORGANOVO HOLDINGS, INC. 10 Nov 2022 1 $0 4 Executive Chairman, Director 14 Nov 2022, 20:10
VIVS ORGANOVO HOLDINGS, INC. 31 Aug 2022 1 $0 4 Executive Chairman, Director 20 Oct 2022, 06:05
VIVS ORGANOVO HOLDINGS, INC. 07 Oct 2021 3 $0 4 Executive Chairman, Director 12 Oct 2021, 18:00
HURA Kintara Therapeutics, Inc. 22 Sep 2021 1 $0 4 Director 22 Sep 2021, 20:43